Abstract 17457: PreSERVE-AMI: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intracoronary Administration of Autologous CD34+ Cells in Patients with Left Ventricular Dysfunction Post STEMI
Arshed A. Quyyumi(Emory University), Andrew L. Pecora(Hackensack University Medical Center), Marc Klapholz(Catholic Medical Center), Timothy D. Henry(Christ Hospital), Vijaykumar S. Kasi(Emory University), AnnaMarie Kanakaraj(Neostem (United States)), Catalin Toma(University of Pittsburgh Medical Center), Alejandro Arias Vásquez(Radboud University Nijmegen), David M. Shavelle(University of Southern California), Douglas W. Losordo(MACOM (United States)), Gary L. Schaer(Rush University), Thomas J. Moss(Neostem (United States)), Roger Gammon, Ali E. Denktas(Michael E. DeBakey VA Medical Center), Steve Frohwein(Emory and Henry College), Vitaly Druker(Neostem (United States)), Le Dich(Neostem (United States)), Ahmed Abdel‐Latif(University of Kentucky), Michael R. Tamberella(Wellmont Health Systems), Ken Fujise(Harborview Medical Center), Nabil Dib(Hôpital Marie Lannelongue), Tanvir Bajwa(Aurora Health Care), Robert Iwaoka(Novant Health), Dean J. Kereiakes(Health Net), Martin Cohen(Westchester Medical Center), Pamela Hyde(Neostem (United States)), Richard A. Schatz(Northwestern University), Charles J. Davidson(Northwestern Memorial Hospital), Gregory W. Barsness(Mayo Clinic in Arizona), Robert A. Preti(Neostem (United States)), Jonathan Sackner‐Bernstein(Neostem (United States))
Unknown
November 25, 2014
Cited by 2
Related Papers
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients
|New England Journal of Medicine|2019|3.6k
Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
|New England Journal of Medicine|2004|2.9k